SAN ANTONIO, Oct. 11, 2012 /PRNewswire/ -- Mission Pharmacal Company today announced that BINOSTO™ (alendronate sodium) Effervescent Tablet for buffered oral solution (70 mg) is now available by ...

Alendronate oral tablet is available as both a generic drug and as brand-name drugs. Brand names: Fosamax and Binosto. Alendronate also comes as an oral solution and an oral effervescent tablet (a ...

In this analysis, 3 bisphosphonates (alendronate, pamidronate, and zoledronic acid) and 1 RANK ligand inhibitor (denosumab) were evaluated for their effectiveness at preventing osteoclasts from ...

WHITEHOUSE STATION, N.J.--Merck, known as MSD outside the United States and Canada, today said a jury found in its favor in the Glynn v. Merck case in the U.S. District Court for the District of New ...

Alendronate is a generic prescription drug that helps prevent and treat osteoporosis and other conditions. Alendronate’s cost may depend on your dosage, whether you have health insurance, and the ...

Alendronate sodium is a bisphosphonate used to treat Paget disease of bone (PDB). The approved dosage of 40 mg/day for 6 months is generally well tolerated, but esophageal irritation can occur if the ...

Bisphosphonate therapy is the current standard of care for the prevention and treatment of glucocorticoid-induced osteoporosis. Studies of anabolic therapy in patients who are receiving long-term ...

Please provide your email address to receive an email when new articles are posted on . Researchers at the University of Southern California (USC) School of Dentistry recently released clinical data ...

WHITEHOUSE STATION, N.J., Oct. 4, 2010 - Merck & Co., Inc. today said it will appeal a decision by the U.S. District Court for the Southern District of New York that reduced the jury verdict from $8 ...

Please provide your email address to receive an email when new articles are posted on . Compared with other first-line osteoporosis treatments, alendronate therapy yielded an increased risk for ...

In re Fosamax (Alendronate Sodium), No. 11-5304, 08-08; U.S. District Court (DNJ); opinion by Pisano, U.S.D.J.; filed June 27, 2013. DDS No. 36-7-xxxx [17 pp.] Fosamax (Alendronate Sodium) is approved ...

For the second time, the U.S. Court of Appeals for the Third Circuit vacated the U.S. District Court for the District of New Jersey’s judgment that plaintiffs’ state law failure-to-warn claims in the ...